Psychopharmacology of the Developmental Disabilities explores the use
of psychotropic and antiepileptic medications in developmentally
disabled patients. A distinguished group of international experts offers
comprehensive coverage of traditional psychotropic as well as novel
pharmacological agents, antiepileptic drugs, and diet and vitamin
treatments. Issues related to litigation, measurement of blood levels,
tardive dyskinesia, and behavioral pharmacology are discussed in detail.
Psychopharmacology of the Developmental Disabilities provides an
excellent overview of what is known about psychoactive drugs and an
awareness of the principal social and medical issues posed by these
agents.